Valuation: Precipio, Inc.

Market Cap 40.9M 35.97M 33.41M 30.73M 57.63M 3.96B 58.66M 400M 156M 1.93B 154M 150M 6.7B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 41.9M 36.85M 34.23M 31.48M 59.04M 4.06B 60.1M 409M 160M 1.98B 157M 154M 6.87B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.41%
Yield 2024 *
-
Yield 2025 -
1 day-2.56%
1 week-3.38%
Current month-7.59%
1 month-1.38%
3 months-15.35%
6 months-6.80%
Current year-0.44%
1 week 22.51
Extreme 22.51
24.75
1 month 22
Extreme 22
27.13
Current year 19.52
Extreme 19.52
33.63
1 year 13.8
Extreme 13.8
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 31/05/2017
Chief Executive Officer 54 27/06/2017
Director TitleAgeSince
Director/Board Member 54 27/06/2017
Director/Board Member 78 25/09/2017
Director/Board Member 67 07/11/2017
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Free

Director

416 0.0233%
15/07/26 Free

Director

520 0.0291%
15/07/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-3.38%+55.86%+252.00% 41.97M
+0.23%-10.20%+15.82%-36.63% 15.8B
+9.95%+6.85%+9.30%+115.26% 1.63B
-0.60%-9.10%-37.67%-80.94% 1.14B
-4.66%-4.60%-37.93%+10.63% 1.01B
+0.57%-6.27%-29.58%-53.93% 627M
+2.48%-10.19%-47.94%-56.93% 505M
+0.56%-0.37%+39.40%-53.79% 449M
-2.94%-6.60%-56.72%-62.88% 372M
-2.25%+1.76%-21.82%-39.30% 350M
Average +0.08%-1.80%-11.13%-0.65% 2.19B
Weighted average by Cap. +0.65%-7.14%+6.05%-26.73%

Financials

2024 2025
Net sales 18.53M 16.3M 15.14M 13.93M 26.12M 1.79B 26.58M 181M 70.62M 875M 69.57M 68.07M 3.04B 24.05M 21.15M 19.65M 18.07M 33.89M 2.33B 34.5M 235M 91.65M 1.14B 90.28M 88.33M 3.94B
Net income -4.29M -3.77M -3.51M -3.22M -6.05M -415M -6.15M -41.91M -16.35M -203M -16.11M -15.76M -703M -363K -319K -297K -273K -512K -35.15M -521K -3.55M -1.38M -17.15M -1.36M -1.33M -59.49M
Net Debt -136K -120K -111K -102K -192K -13.17M -195K -1.33M -518K -6.42M -511K -500K -22.29M 1M 881K 819K 753K 1.41M 97.04M 1.44M 9.79M 3.82M 47.33M 3.76M 3.68M 164M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
23/07/26 US$22.88 -2.56% 94,205
22/07/26 US$23.48 -0.93% 254,918
21/07/26 US$23.70 +1.28% 85,145
20/07/26 US$23.40 -5.03% 109,126
17/07/26 US$24.64 +4.05% 108,324
  1. Stock Market
  2. Stocks
  3. PRPO Stock